|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Retrophin Inc [RTRX]
$18.80 0.31 (1.68%)
Market Cap 780 Million
Retrophin Inc serves in the healthcare sector based in the United States. As a pharmaceutical products manufacturer, it develops drugs to treat serious and rare diseases. Its suite of drug candidates includes Chenodal, to combat gallstones; Cholbam, which is approved for the treatment of bile acid synthesis disorders and Thiola, which addresses kidney stone formation.
EPS -0.99 P/E Ratio 0.00
Previous Earnings Tue, Feb 26, 2019
Pay Date --